Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Exchange Rate Effect (2016 - 2025)

Angiodynamics (ANGO) has disclosed Exchange Rate Effect for 16 consecutive years, with -$72000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Exchange Rate Effect rose 76.39% year-over-year to -$72000.0, compared with a TTM value of $706000.0 through Nov 2025, up 365.41%, and an annual FY2025 reading of $398000.0, up 218.4% over the prior year.
  • Exchange Rate Effect was -$72000.0 for Q4 2025 at Angiodynamics, down from $191000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $715000.0 in Q2 2025 and bottomed at -$316000.0 in Q3 2022.
  • Average Exchange Rate Effect over 5 years is $11300.0, with a median of -$2000.0 recorded in 2023.
  • The sharpest move saw Exchange Rate Effect plummeted 1231.58% in 2021, then skyrocketed 1291.67% in 2025.
  • Year by year, Exchange Rate Effect stood at -$215000.0 in 2021, then skyrocketed by 186.98% to $187000.0 in 2022, then grew by 1.07% to $189000.0 in 2023, then plummeted by 261.38% to -$305000.0 in 2024, then soared by 76.39% to -$72000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for ANGO at -$72000.0 in Q4 2025, $191000.0 in Q3 2025, and $715000.0 in Q2 2025.